Study of Glaucoma Treatment With Food Additives
Phase 1
Terminated
- Conditions
- Glaucomatous Neuropathy
- Registration Number
- NCT00196677
- Lead Sponsor
- Future Products Management
- Brief Summary
The purpose of this study is to determine if certain food additives are effective in the treatment of glaucoma, improving and reversing the progress of the disease.
- Detailed Description
Glaucomatous neuropathy is a condition that worsens with time causing atrophy of the optic nerve and narrowing of the visual field which may culminate in blindness. The treatment tested in the trial employs certain food additives intended to reverse this pathology.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
- Stable open angle glaucoma - with equilibrated eye internal pressure
- Above the age of 50 years and have severe damage that does not progress to the vision field in the upper and lower half. Scoring of the vision field will be made according to the Agis study instructions.
Exclusion Criteria
- Eye diseases excluding past cataract operation
- Allergy to one of the components in the preparation
- Deterioration in the vision field in the last year
- Kidney diseases, gastrointestinal (G.I.) tract, liver diseases, coagulation problems and thyroid diseases
- Persons who take steroids
- Diabetics or unbalanced hyperglycemia
- Autoimmune diseases
- Hypertension (not responding to treatment)
- Psychiatric treatment with drugs, psychiatric pathologies
- Pregnancy
- Ability to take more than 3 pills per day regularly
- Smoking
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Improvement in vision field (Protocol24) in a Humphrey's instrument. Scoring according to the Agis study
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sheba Medical Center
🇮🇱Tel Hashomer, Israel